The present application is related to compounds represented by Formula I, which are novel allosteric modulators of α7nAChR. The application also discloses the treatment of disorders that are responsive to modulation of acetylcholine action on α7nAChR in a mammal by administering an effective amount of a compound of Formula I.
本申请涉及由公式I所代表的化合物,它们是α7nAChR的新型变构调节剂。该申请还披露了通过给哺乳动物施加公式I化合物的有效量来治疗对
乙酰胆碱作用于α7nAChR敏感的疾病。